Winzeler lab awarded MMV Project of the Year

Dr Winzeler received the award for her contributions to antimalarial drug discovery, which in part led to the identification of KAF156 and Cipargamin as antimalarial compounds, both of which are now in clinical development with Novartis and MMV. Read more…

Evolve and survive

Directed evolution is an experimental strategy that is used to mimic natural selection to generate a library of biomolecule variants. Read more…

Gates Foundation boosts UCSD-led malaria research

The Bill and Melinda Gates Foundation has awarded a $4.7 million supplemental grant to a UC San Diego-led research consortium to develop therapies to eradicate malaria. Read more…

New Grant Boosts UC San Diego-Led Malaria Research Program

An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination. Read more…

Start typing and press Enter to search